FDA approves new class of non-opioid pain medication

A child kissing their father on the cheek

The U.S. Food and Drug Administration (FDA) recently approved a new prescription pain reliever for adults with moderate to severe acute pain. The drug—branded as Journavx®—is the first in a new class of pain meds that will soon be available nationwide.

“This is really exciting news because for the first time in more than 20 years, we’re developing a brand-new class of analgesics,” says Dr. Jason Smith, MD, an interventional pain physiatrist at Atlantic Health.

How does it work?

Dr. Smith explains this groundbreaking non-opioid medication does not affect the brain’s reward center the way opioids do. Instead, it targets selective pain pathways, blocking the sodium channels that stimulate pain.

What conditions does it treat?

This oral medication is currently FDA-approved solely for short-term pain management use. This includes postsurgical pain, trauma, and acute back pain or osteoarthritic injuries, depending on the severity.

Are there side effects?

Although some patients experience side effects, studies show most responses to Journavx® are relatively mild. Adverse reactions can include itching, rash, or muscle spasms, and may be more severe in patients who are sensitive to these issues.

Three existing classes of prescription pain relievers

Prescription-strength Tylenol® (acetaminophen) disrupts pain signals in the body, making it effective for mild to moderate pain. It lower fevers and relieves aches and pains. However, acetaminophen does not reduce inflammation in the body.
Non-steroid anti-inflammatory drugs (NSAIDs) treat mild to moderate pain by blocking certain enzymes (Cox-1 and Cox-2) and producing prostaglandins that decrease pain, inflammation, and swelling.
Opioids act on the brain’s reward centers. Although opioids are strong and effective, they come with a significant risk of addiction, which has fueled an epidemic of dependency and overdose.

“I describe the three classes of pain medications like a radio station,” says Dr. Smith. “Tylenol® turns down the volume. NSAIDS stop the broadcast altogether. Opioids block the broadcast and play music – songs you want to hear again and again.”

Ushering in a new class of pain relievers

According to Dr. Smith, opioids will always be an effective way to treat short-term pain. What’s needed is a safe long-term way to treat moderate to severe pain. This promising new drug class just might be the answer.

“For now, this new medication is being marketed for severe acute pain,” says Dr. Smith. “But at some point, I wouldn't be surprised if it’s extended to manage long-term pain, too. It’s got a lot of potential.”

Is it time to talk to your doctor?

Despite the drug’s limited availability and insurance coverage, Dr. Smith encourages patients to talk with their doctors about pain management options.

“Patients are already hearing about Journavx® and asking questions,” he says. “It’s important to talk with your health care provider about new advancements in health care.”

Find an Orthopedist

Published: April 30, 2025

Press ReleaseThree Atlantic Health medical centers earn top five-star rating from CMS Atlantic Health earns top Centers for Medicare and Medicaid Services (CMS) hospital ratings in 2026, with three medical centers achieving five stars and all six receiving four stars or higher.

Patient StoriesPlainfield man’s cosmetic procedure becomes a fight for survivalA vacation overseas became a life-threatening medical crisis for 29-year-old DD — but also an extraordinary story of survival, resilience and advanced care delivered by Atlantic Health.

Press ReleaseAtlantic Health introduces Phagenyx®: Advanced therapy for post-stroke swallowing disordersAtlantic Health is among the first in New Jersey to use the Phagenyx® System to improve swallowing recovery for stroke patients with severe dysphagia.

Press ReleaseAtlantic Health Overlook Medical Center cardiologists introduce new tool to reduce blood pressure by calming renal nervesAtlantic Health Overlook Medical Center now offers FDA-approved renal denervation, a minimally invasive procedure to help control high blood pressure.

Press ReleaseAtlantic Health hospitals set safety standard with Leapfrog “A” Grade Five Atlantic Health medical centers earned Leapfrog ‘A’ Hospital Safety Grades for Spring 2026, highlighting excellence in patient safety and quality care.

OrthopedicsCommon soccer injuries and how to stay in the gameLearn how to treat common soccer injuries, prevention strategies to help avoid them — and when you should see a doctor.

Mental WellnessRecognizing the signs of autism in adultsAutism is being diagnosed well into adulthood. An Atlantic Health expert explains why more adults may be on the autism spectrum—and shares some common traits.

OrthopedicsShoulder replacement surgery recovery: How to prepare and what to expect An orthopedic surgeon shares the most important things you can do before and after shoulder replacement surgery to make recovery easier.

Cold, Flu & VirusesHand, foot and mouth disease: What parents should knowLearn the symptoms of hand, foot and mouth disease and ways to prevent it from an expert at Atlantic Health.

AllergyPoison ivy, oak and sumac: Is everyone allergic? Learn about poison ivy, oak and sumac, how to ease symptoms and how to avoid these irritating plants from an expert at Atlantic Health.

articleFive ways to protect your bones from osteoporosis Bone loss starts earlier than you think. But according to this Atlantic Health expert, a few everyday habits can make a big difference in staying ahead of osteoporosis.

OrthopedicsWhat is sports medicine?Learn what sports medicine is and who can benefit from this specialty care from an expert at Atlantic Health.